Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers
about
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusionsDevelopment of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma
P2860
Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Improving the utility of prost ...... derivatives and novel markers
@ast
Improving the utility of prost ...... derivatives and novel markers
@en
type
label
Improving the utility of prost ...... derivatives and novel markers
@ast
Improving the utility of prost ...... derivatives and novel markers
@en
prefLabel
Improving the utility of prost ...... derivatives and novel markers
@ast
Improving the utility of prost ...... derivatives and novel markers
@en
P2093
P2860
P356
P1476
Improving the utility of prost ...... derivatives and novel markers
@en
P2093
P2860
P304
P356
10.1136/PMJ.78.925.646
P407
P577
2002-11-01T00:00:00Z